[go: up one dir, main page]

GB1509778A - Pharmaceutical composition and dosage units thereof - Google Patents

Pharmaceutical composition and dosage units thereof

Info

Publication number
GB1509778A
GB1509778A GB4467775A GB4467775A GB1509778A GB 1509778 A GB1509778 A GB 1509778A GB 4467775 A GB4467775 A GB 4467775A GB 4467775 A GB4467775 A GB 4467775A GB 1509778 A GB1509778 A GB 1509778A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
dosage units
bendroflumethazide
timolol
antihypertensive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4467775A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Priority to GB4467775A priority Critical patent/GB1509778A/en
Priority to IE224076A priority patent/IE43955B1/en
Priority to NL7611731A priority patent/NL187048C/en
Priority to FR7632413A priority patent/FR2329283A1/en
Publication of GB1509778A publication Critical patent/GB1509778A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

1509778 Antihypertensive compositions LEO PHARMACEUTICAL PRODUCTS Ltd AS 12 Oct 1976 [7 Nov 1975] 44677/75 Heading A5B Pharmaceutical compositions having antihypertensive activity comprise bendroflumethazide and S-(-)-1-tert-butylamino-3-(4-morpholino-1, 2, 5-thiadiazol-3-yloxy) - 2 - propanol (timolol) or an acid addition salt thereof, optionally together with a pharmaceutically acceptable carrier, the ratio by weight of the bendroflumethazide to the timolol being between 1:5 and 5:1.
GB4467775A 1975-10-29 1975-10-29 Pharmaceutical composition and dosage units thereof Expired GB1509778A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB4467775A GB1509778A (en) 1975-10-29 1975-10-29 Pharmaceutical composition and dosage units thereof
IE224076A IE43955B1 (en) 1975-10-29 1976-10-12 Pharmaceutical composition and dosage units thereof
NL7611731A NL187048C (en) 1975-10-29 1976-10-22 METHOD FOR PREPARING A MEDICINE FOR THE TREATMENT OF EXCESSIVE BLOOD PRESSURE
FR7632413A FR2329283A1 (en) 1975-10-29 1976-10-27 PREPARATION AND PHARMACEUTICAL UNIT FORMS AND THEIR PREPARATION PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4467775A GB1509778A (en) 1975-10-29 1975-10-29 Pharmaceutical composition and dosage units thereof

Publications (1)

Publication Number Publication Date
GB1509778A true GB1509778A (en) 1978-05-04

Family

ID=10434314

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4467775A Expired GB1509778A (en) 1975-10-29 1975-10-29 Pharmaceutical composition and dosage units thereof

Country Status (4)

Country Link
FR (1) FR2329283A1 (en)
GB (1) GB1509778A (en)
IE (1) IE43955B1 (en)
NL (1) NL187048C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327080A (en) 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
EP0154009A1 (en) * 1983-12-09 1985-09-11 Euro-Celtique S.A. Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327080A (en) 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
AU602899B2 (en) * 1983-12-07 1990-11-01 Euro-Celtique S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
EP0154009A1 (en) * 1983-12-09 1985-09-11 Euro-Celtique S.A. Use of a thiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament

Also Published As

Publication number Publication date
IE43955L (en) 1977-04-29
NL187048B (en) 1990-12-17
FR2329283A1 (en) 1977-05-27
NL187048C (en) 1991-05-16
NL7611731A (en) 1977-05-03
IE43955B1 (en) 1981-07-15
FR2329283B1 (en) 1978-11-10

Similar Documents

Publication Publication Date Title
HK12184A (en) Substituted ortho-anisamides, methods of preparing them, compositions containing them and their application as psychotropic agents
ES8500739A1 (en) Extended action controlled release compositions.
IE45256L (en) Quinazolone derivatives
DE2862419D1 (en) Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
GB1298494A (en) Phenylethanolamine derivatives
ES485067A1 (en) Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof
IE792241L (en) Hydroxypropyltriazoles
AU528098B2 (en) Analgesic tablet
GB1271466A (en) Thiocarbamic acid derivatives
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB1509778A (en) Pharmaceutical composition and dosage units thereof
GB1525971A (en) Deodorant composition
GB1421589A (en) Salicylanilide derivatives
IE34590L (en) Phenylethanolamine derivatives
GB1500300A (en) Pharmaceutical preparation for the treatment of circulatory disorders
GB1449404A (en) N-arylsulphonyl urea derivatives
IE35492B1 (en) 2-benzylphenols their preparation and compositions containing them
GB1359044A (en) Quinoline derivatives
ES8303297A1 (en) New peptide, process for preparation thereof and use thereof.
GB1465771A (en) Pharmaceutical composition and use thereofd
GB1437788A (en) Therapeutic compositions
GB1470747A (en) Pyridazine derivative
GB1287433A (en) Pharmaceutical compositions
ES8304924A1 (en) Peptide, process for preparation thereof and use thereof.
GB1471371A (en) Cyclopenteno-b-pyridine derivative

Legal Events

Date Code Title Description
PS Patent sealed
701A Proceeding under schedule 1 paragraph 4a of the patents act 1977 ** application made to the patents court
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19951012